Clinical trial
Clinical Effects of Cardiac Contractility Modulation (CCM) With the OPTIMIZER III System in Subjects With Heart Failure Caused by Left Ventricular Dysfunction
NCT02895048 is registered in ClinicalTrials.gov with Stiftung Institut fuer Herzinfarktforschung as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Effects of Cardiac Contractility Modulation (CCM) With the OPTIMIZER III System in Subjects With Heart Failure Caused by Left Ventricular Dysfunction
- Lead sponsor
- Stiftung Institut fuer Herzinfarktforschung
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- November 30, 2013
- Enrollment
- 184 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.